BPC-157 and Telmisartan Interaction

Q: Can I take BPC-157 with Telmisartan?

Yes, BPC-157 and Telmisartan can generally be taken together. BPC-157 reduces inflammation while Telmisartan promotes tissue repair. Reducing inflammation creates a more favorable environment for healing.

Q: Is BPC-157 and Telmisartan safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: teratogenic. Monitor accordingly.

Q: How should I time BPC-157 and Telmisartan?

BPC-157 has a half-life of <30 minutes and Telmisartan has a half-life of ~24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Synergistic

Mechanism-based 50% confidence

BPC-157 and Telmisartan have a synergistic interaction with 50% confidence. BPC-157 reduces inflammation while Telmisartan promotes tissue repair. Reducing inflammation creates a more favorable environment for healing. These compounds primarily affect different organ systems.

Compound Profiles

BPC-157

Body Protection Compound-157 | Pentadecapeptide

Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..

Half-life: <30 minutes Typical dose: 250-500mcg healing, longevity

vegf anticoagulantcarcinogenic riskpro angiogenicteratogenic

View full profile

Telmisartan

Angiotensin II Receptor Blocker | Cardiac Protection On Cycle

Telmisartan selectively blocks the angiotensin II type 1 (AT1) receptor, preventing angiotensin II from exerting its vasoconstrictive, aldosterone-secreting, and pro-fibrotic effects. By antagonizing AT1, telmisartan lowers systemic vascular resistance and blood pressure while simultaneously reducing pathological cardiac and vascular remodeling.

Half-life: ~24 hours Typical dose: 20-80 mg/day cardiovascular

ppar gamma blood pressure raisinghepatotoxicinsulin sensitizingteratogenic

View full profile

Combined Organ Load

Blood Vessels

low

Heart

low

Shared Safety Flags

2x 2 compounds share the teratogenic safety flag (BPC-157, Telmisartan). Monitor accordingly.

Frequently Asked Questions

Can I take BPC-157 with Telmisartan?

Yes, BPC-157 and Telmisartan can generally be taken together. BPC-157 reduces inflammation while Telmisartan promotes tissue repair. Reducing inflammation creates a more favorable environment for healing.

Is BPC-157 and Telmisartan safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between BPC-157 and Telmisartan?

BPC-157 reduces inflammation while Telmisartan promotes tissue repair. Reducing inflammation creates a more favorable environment for healing. This assessment has 50% confidence and is inferred from pharmacological mechanism analysis.

How should I time BPC-157 and Telmisartan?

BPC-157 has a half-life of <30 minutes and Telmisartan has a half-life of ~24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: BPC-157 vs Telmisartan

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.